Humanwell Healthcare Group and PuraCap Pharmaceutical have acquired Epic Pharma for $550 million. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The acquisition of Epic will provide a robust generic product portfolio, which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances....